Cargando…

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

BACKGROUND: Pre-clinical studies have demonstrated synergistic anti-tumour effects of chemotherapy (CT) and zoledronic acid (ZOL). Within the AZURE trial, designed to determine whether the addition of ZOL to neoadjuvant therapy improves disease outcomes, a subgroup received neoadjuvant CT. We report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, R E, Winter, M C, Cameron, D, Bell, R, Dodwell, D, Keane, M M, Gil, M, Ritchie, D, Passos-Coelho, J L, Wheatley, D, Burkinshaw, R, Marshall, S J, Thorpe, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093/ https://www.ncbi.nlm.nih.gov/pubmed/20234364 http://dx.doi.org/10.1038/sj.bjc.6605604

Ejemplares similares

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
por: Coleman, R.E., et al.
Publicado: (2018)

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
por: Veltman, J D, et al.
Publicado: (2010)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – An AZURE (BIG 01/04) sub-study
por: Wilson, Caroline, et al.
Publicado: (2016)

Tumour Cell Invasion from Transplantable Ascites Tumours into Host Tissues
por: Wheatley, D. N., et al.
Publicado: (1964)

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
por: Kroep, J.R., et al.
Publicado: (2015)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015)

Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials
por: Coleman, Robert E., et al.
Publicado: (2013)

Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis
por: Boam, T D, et al.
Publicado: (2021)

Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study
por: Glass, O K, et al.
Publicado: (2015)

The effect of liver interference on mammary tumour induction by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats.
por: Kernohan, I. R., et al.
Publicado: (1967)

On Umbilical Hœmorrhage and Tumour
por: Ritchie, R. Peel
Publicado: (1868)

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
por: Insalaco, Lavinia, et al.
Publicado: (2012)

An added dimension to tumour TRAIL sensitivity
por: Healy, Sandra, et al.
Publicado: (2015)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Adult granulosa cell tumour of the testis: an uncommon tumour
por: Wahlstedt, Eric R, et al.
Publicado: (2022)

Differentiation Between the Embryonic and Tumour Specific Antigens on Chemically Induced Rat Tumours
por: Baldwin, R. W., et al.
Publicado: (1974)

Mammary tumours induced in Sprague-Dawley female ats by 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.
por: Wheatley, D. N., et al.
Publicado: (1968)

The Growth and Infiltration of Ehrlich's Ascites Tumour in Mice with Reduced Immunological Responses
por: Wheatley, D. N., et al.
Publicado: (1964)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamide.
por: Olsson, A. R., et al.
Publicado: (1996)

Glutathione S-transferase isoenzymes in human tumours and tumour derived cell lines.
por: Lewis, A. D., et al.
Publicado: (1989)

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
por: Coscia, Marta, et al.
Publicado: (2010)

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer
por: Duivenvoorden, W C M, et al.
Publicado: (2007)

Placental site trophoblastic tumour: a rare but potentially curable cancer
por: Gillespie, A M, et al.
Publicado: (2000)

Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response
por: Stevens, William, et al.
Publicado: (2021)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Cimetidine and therapy of rodent tumours.
por: Hannant, D., et al.
Publicado: (1982)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Parotid tumours.
por: Bell, M., et al.
Publicado: (1970)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

On the clonality of tumours.
por: Woodruff, M. F., et al.
Publicado: (1985)

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency
por: Coleman, M G, et al.
Publicado: (2001)

Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.
por: Miller, B. E., et al.
Publicado: (1987)

MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression
por: Presneau, N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oc79itdep4o1v0flkrj95vg7fh